Clinical study of Cangshan Taiyang Moxibution Acupoint Application on chronic heart failure
- Conditions
- chronic heart failure
- Registration Number
- ITMCTR2000004175
- Lead Sponsor
- onghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1. Patients with chronic heart failure in stage C diagnosed by western medicine.
2. Patients with heart failure diagnosed by TCM as Yang Qi deficiency and blood stasis syndrome.
3. Aged 35-80 years, regardless of gender.
4. Patients who have signed informed consent.
1. Pregnant and lactating women;
2. Patients with chronic heart failure who need medical treatment in the near future, patients with acute coronary syndrome (within 30 days), cardiogenic shock, acute myocarditis, hypertension (systolic blood pressure >= 180 mmHg and / or diastolic blood pressure >= 110 mmHg), malignant arrhythmia, hypertrophic obstructive cardiomyopathy, severe valvular disease requiring surgical treatment and pulmonary embolism;
3. Patients with other serious diseases: severe hepatic and renal insufficiency, severe anemia, psychosis, malignant tumor, etc.;
4. Have a history of allergy to topical drugs in the past;
5. Other researchers in recent 2 months.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method cardiac function classification;TCM syndrome score;6-minute walking test;
- Secondary Outcome Measures
Name Time Method B-type brain natriuretic peptide;echocardiography;Minnesota Living with Heart Failure Questionnaire;